Current Report Filing (8-k)
15 July 2022 - 7:21AM
Edgar (US Regulatory)
0001849058
false
0001849058
2022-07-14
2022-07-14
0001849058
CLOE:UnitsEachConsistingOfOneShareOfClassCommonStock0.0001ParValueAndOneRightToReceiveOneeighth18OfOneShareOfClassCommonStockUponConsummationOfInitialBusinessCombinationMember
2022-07-14
2022-07-14
0001849058
CLOE:ClassCommonStockParValue0.0001PerShareMember
2022-07-14
2022-07-14
0001849058
CLOE:RightsEveryEight8RightsEntitlesHolderToReceiveOneShareOfClassCommonStockUponConsummationOfInitialBusinessCombinationMember
2022-07-14
2022-07-14
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July
14, 2022
Clover Leaf Capital Corp.
(Exact name of registrant as specified in its charter)
Delaware |
|
001-40625 |
|
85-2303279 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
1450 Brickell Avenue, Suite 2520
Miami, FL 33131
(Address of principal executive offices, including
zip code)
Registrant’s telephone number, including
area code: (305) 577-0031
Not Applicable
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Units, each consisting of one share of Class A Common Stock, $0.0001 par value and one Right to receive one-eighth (1/8) of one share of Class A Common Stock upon the consummation of an initial business combination |
|
CLOEU |
|
The Nasdaq Stock Market LLC |
|
|
|
|
|
Class A Common Stock, par value $0.0001 per share |
|
CLOE |
|
The Nasdaq Stock Market LLC |
|
|
|
|
|
Rights, every eight (8) rights entitles the holder to receive one share of Class A Common Stock upon the consummation of an initial business combination |
|
CLOER |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether
the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 8.01. Other Events.
On July 14, 2022, Clover Leaf
Capital Corp. (the “Company”) issued a press release announcing that its sponsor, Yntegra Capital Investments, LLC
(the “Sponsor”), has requested that the Company extend the date by which the Company has to consummate a business combination
from July 22, 2022 to October 22, 2022 (the “Extension”). The Extension is the first of three three-month extensions
permitted under the Company’s governing documents. In connection with the Extension, the Sponsor has notified the Company that it
intends to deposit an aggregate of $1,383,123 (representing $0.10 per public share) into the Company’s trust account on or before
July 22, 2022. The Extension provides the Company with additional time to complete its initial business combination.
A copy of the press release
is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Clover Leaf Capital Corp. |
|
|
|
|
By: |
/s/ Felipe MacLean |
|
|
Name: |
Felipe MacLean |
|
|
Title: |
Chief Executive Officer |
|
|
|
Dated: July 14, 2022 |
|
|
2
Clover Leaf Capital (NASDAQ:CLOEU)
Historical Stock Chart
From Jun 2024 to Jul 2024
Clover Leaf Capital (NASDAQ:CLOEU)
Historical Stock Chart
From Jul 2023 to Jul 2024